Trials / Withdrawn
WithdrawnNCT02948855
Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases
Study on Regulation of LncRNA to Regulatory B Cells(Bregs) Through Notch Pathway in Patients With Thymoma and Autoimmune Diseases
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Initially investigators will find LncRNA which to be able to affect Notch2 signaling pathway; then confirm the relationship between Notch2 and LncRNA, and analysis the regulation mode of LncRNA to Notch2 signaling pathway, and to observe the correlation between LncRNA and thymoma complicated with autoimmune diseases.
Detailed description
1. This study plans to research the correlation between Bregs and thymoma complicated with autoimmune diseases and the regulation the severity of the disease. 2. Clarify different expression levels of Notch2 signaling pathway in thymoma complicated with autoimmune diseases, and the effect on Regulatory B Cells(Bregs). 3. Find the effective regulation mode of Notch2 signaling pathway and the regulation of Bregs cell development and function in LncRNA.
Conditions
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2018-05-01
- Completion
- 2018-05-01
- First posted
- 2016-10-31
- Last updated
- 2018-05-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02948855. Inclusion in this directory is not an endorsement.